Skip to main content
Premium Trial:

Request an Annual Quote

Francois Martelet

Novigenix has appointed Francois Martelet as a non-executive director. Martelet recently retired as CEO at NetScientific. He was also chairman of several companies, including Vortex BioSciences, Wanda, Glycotest, and ProAxsis. Prior to that, Martelet was CEO at Topotarget and held senior commercial roles at Novartis Pharma and Merck.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.